Anti-programmed cell death 1 (PD-1) or anti-PD-ligand (L) 1 drugs, as classic immune
checkpoint inhibitors, are considered promising treatment strategies for tumors. In clinical …

Cancer radio-immunotherapy, integrating external/internal radiation therapy with immuno-
oncology treatments, emerges in the current management of cancer. A growing number of …

In the tumor microenvironment (TME), tumor-associated macrophages (TAMs) are the most
abundant immune cells, which act as a key regulator in tumorigenesis and progression …

The incidence of liver cancer is continuously rising where hepatocellular carcinoma (HCC)
remains the most common form of liver cancer accounting for approximately 80–90% of the …

Dynamic therapy (DT) has emerged as a promising cancer therapy due to its non-invasive
treatment and good spatiotemporal control. However, the efficiency of DT is restricted by …

Tumor hyaluronan (HA) accumulation is closely associated with the formation of a hypoxic
microenvironment that is highly immunosuppressive and severely hinders the efficacy of …

Radiosensitization efficacy of conventional tumor radiosensitizers has been frequently
limited by insufficient competence for tumor microenvironment (TME) regulation and …

Nickel oxide (NiO) nanoparticles are essential to developing a wide range of important
industrial products, examples of which include electrodes, catalysts, and sensors, leading to …

Liver cancer remains a global health challenge with a projected incidence of over one
million cases by 2025. Hepatocellular carcinoma (HCC) is a common primary liver cancer …

Chemotherapy is indispensable for the systematic treatment of aggressive malignancies,
such as pancreatic ductal adenocarcinoma (PDAC), while delivery vehicles are essential for …